Brief: QuidelOrtho Receives FDA 510(k) Clearance for VITROS Immunodiagnostic Products hs Troponin I Assay
03/11/2025 12:58
Nov 3 (Reuters) - Quidelortho Corp QDEL.O: QUIDELORTHO RECEIVES FDA 510(K) CLEARANCE FOR VITROS™ IMMUNODIAGNOSTIC PRODUCTS HS TROPONIN I ASSAY QUIDELORTHO CORP - COMMERCIAL ROLLOUT FOR U.S. LABORATORIES OPERATING VITROS SYSTEMS TO BEGIN LATER THIS YEAR Source text: ID:nPn3tnQF8a Further company coverage: QDEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quidelortho
See all newsBrief: Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026
QuidelOrtho Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: QuidelOrtho Q2 EPS USD -1.36
Media: QuidelOrtho looks to sell testing unit as PE circles healthcare companies - FT
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras